KR0136642B1 - Novel enterobacter which produce l-leucine from methyl isobutyl ketone and l-leucine producing method - Google Patents

Novel enterobacter which produce l-leucine from methyl isobutyl ketone and l-leucine producing method

Info

Publication number
KR0136642B1
KR0136642B1 KR1019950005878A KR19950005878A KR0136642B1 KR 0136642 B1 KR0136642 B1 KR 0136642B1 KR 1019950005878 A KR1019950005878 A KR 1019950005878A KR 19950005878 A KR19950005878 A KR 19950005878A KR 0136642 B1 KR0136642 B1 KR 0136642B1
Authority
KR
South Korea
Prior art keywords
leucine
methyl isobutyl
isobutyl ketone
acetone
produce
Prior art date
Application number
KR1019950005878A
Other languages
Korean (ko)
Other versions
KR960034400A (en
Inventor
정선미
김용식
Original Assignee
김흥기
금호석유화학주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김흥기, 금호석유화학주식회사 filed Critical 김흥기
Priority to KR1019950005878A priority Critical patent/KR0136642B1/en
Publication of KR960034400A publication Critical patent/KR960034400A/en
Application granted granted Critical
Publication of KR0136642B1 publication Critical patent/KR0136642B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • C12P13/06Alanine; Leucine; Isoleucine; Serine; Homoserine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

본 발명은 아세톤 자화능을 갖는 미생물을 이용하여 메틸이소부틸키톤과 같은 알파위치에 카보닐기를 갖는 메틸키톤류 물질을 산화시켜 엘-류신(L-Leucine)을 제조하는 방법과 메틸이소부틸키톤으로부터 엘-류신을 생산하는 새로운 미생물에 관한 것이다. 즉, 토양으로부터 아세톤을 단일 탄소원으로하여 성장하는 미생물을 분리하고 미생물 촉매에 트리톤엑스-100을 처리하여 세포의 투과성을 증진시킨 후, 용매로서 많이 사용되는 메틸이소부틸키톤으로부터 직접 아미노산 엘-류신을 생합성하는 방법에 관한 것이다. 메틸이소부틸키톤으로부터 미생물 촉매를 이용하여 엘-류신을 생산하는 제조방법으로서는 최초의 것이다.The present invention provides a method for producing L-Leucine by oxidizing a methyl ketone material having a carbonyl group in an alpha position such as methyl isobutyl ketone using a microorganism having acetone magnetization and from methyl isobutyl ketone. It relates to a new microorganism that produces L-leucine. That is, acetone is used as a single carbon source to separate growing microorganisms and triton-X-100 is treated with microbial catalysts to enhance cell permeability. It relates to a method of biosynthesis. It is the first manufacturing method to produce el-leucine using a microbial catalyst from methyl isobutyl ketone.

Description

메틸이소부틸키톤으로부터 엘-류신을 생산하는 새로운 미생물 및 그 미생물을 이용하는 엘-류신의 제조방법New microorganisms producing L-leucine from methyl isobutyl ketone and a method for producing L-leucine using the microorganisms

본 발명은 아세톤(Acetone)을 단일 탄소원으로 사용하여 성장하며 메틸이소부틸키톤(Methl Isobutyl Ketone)으로부터 엘-류신(L-Leucine)을 생산하는 새로운 미생물과 그 미생물을 이용하여 메틸이소부틸키톤으로부터 아미노산의 일종인 엘-류신을 제조하는 방법에 관한 것이다. 엘-류신은 여러 가지 방법으로 만들어질 수 있다. 유기합성을 통하여 류신을 합성하는 방법은 공지의 사실이다. 그러나 이 경우 주로 먼저 디,엘-류신(D,L-Leucine)의 광학적 이성질체의 혼합물로 만들어지며 이를 이후 여러 가지 방법으로 분리하여 엘-류신만을 얻을 수 있다. 엘-류신은 역시 코리네폼 박테리아(Coryneform bactera) 등을 이용하여 발효를 통하여서도 만들어지기도 한다. 엘-류신은 공업적으로 단백질을 가수분해하여 만들어진다. 이 과정에서 유사한 엘-이소류신(L-Isoleucine)과의 분리를 위하여 여러 가지의 방법이 개발되어있다(미합중국특허 4562153, 4731476, 4820869 참조) 미생물 촉매를 이용하여 전구물질을 공급하는 방법으로 메틸이소부틸키톤의 메틸기가 산화된 형태의 아래의 분자식(I)로 표시되는 키토-이소카프록산(keto-isocarproic acid)에서 미생물의 아미노(transaminase)에 의하여 키토-이소카프록산의 카보닐를 아미노기로 치환하여 아래의 분자식(III)으로 표시되는 엘-류신을 생산하는 방법이 알려져 있다.(Biotech. Bioeng., 27(II) : 1616-1619, 1985) 그러나 키토-이소카프록산은 쉽게 저가로 얻을 수 있는 물질이 아니므로 원료 물질로서 부적합하다는 단점이 있다. 동시에 아미노기의 전이에 필요한 에너지를 공급하기 위하여 연속적으로 조효소를재생시켜 주어야 한다는 단점이 있다. 이와같은 문제점을 고려하여 본 발명에서는 현재 용매로서 많이 사용되는 아래의 분자식(II)로 표시되는 메틸이소부틸카톤을 출발 물질로하여 아래의 분자식(III)으로 표시되는 엘-류신을 생합성하는 미생물을 자연계의 토양에서 순수 분리하였다. 메틸이소부틸키톤은 키토-이소카프록산의 탄산기가 환원된 형태로써 용매로서 사용되며 본 발명에서는 이 메틸기를 직접 산화시킬 수 있는 능력을 가지며 미생물 즉, 아세톤을 탄소원으로 성장하는 미생물을 분리하여 메틸이소부틸키톤으로 직접 아미노산을 생합성하는 법이다. 그러나 본 발명에서 주장하는 메틸이소부틸키톤으로부터 미생물 촉매로 엘-류신을 생산하는 방법은 아직 보고된 바가 없는 신규의 것이다.The present invention grows using acetone as a single carbon source and grows L-Leucine from methyl isobutyl ketone and amino acid from methyl isobutyl ketone using the microorganism. It relates to a method for producing el-leucine which is a kind of. L-leucine can be made in several ways. The method for synthesizing leucine through organic synthesis is well known. In this case, however, it is mainly made of a mixture of optical isomers of D, L-Leucine, which can then be separated by various methods to obtain only L-leucine. L-leucine is also produced through fermentation using Coryneform bactera. L-leucine is produced industrially by hydrolyzing proteins. In this process, various methods have been developed for separation from similar L-isosolecin (see US Pat. No. 4562153, 4731476, 4820869). Methyl isobutyl In the keto-isocarproic acid represented by the following molecular formula (I) in the oxidized form of the ketone, the carbonyl of the chito-isocaproxane is substituted with an amino group by transaminase of the microorganism. However, a method for producing el-leucine represented by the molecular formula (III) is known. (Biotech. Bioeng., 27 (II): 1616-1619, 1985) However, chito-isocaproxane is an easily obtainable substance at low cost. Because of this, there is a disadvantage that it is not suitable as a raw material. At the same time, there is a disadvantage in that coenzymes must be continuously regenerated in order to supply energy required for the transfer of amino groups. In view of the above problems, the present invention provides a microorganism which biosynthesizes L-leucine represented by the following molecular formula (III) using methyl isobutyl carton represented by the following molecular formula (II) as a starting material. Pure separation from natural soils. Methyl isobutyl ketone is a reduced form of the carbonic acid group of the chito-isocaproxane, and is used as a solvent. Biosynthesis of amino acids directly with butyl ketone. However, the method of producing el-leucine by the microbial catalyst from methyl isobutyl ketone claimed in the present invention is a novel one that has not been reported yet.

본 발명을 상세히 설명하면 다음과 같다. 아세톤을 유일한 탄소원으로하여 성장하는 미생물은 아세톤의 메틸기를 산화시켜 차례로 아세톨로 만들고 이를 차례로 산화시켜 아세탈을 만들고 이를 계속 산화시켜 생성되는 피루빅산을 이용하여 성장한다. 즉, 말단의 메틸기를 연속적으로 산화시켜 생합성한 피루빅산을 이용하여 세포의 여러 구성성분을 합성한다. 본 발명은 아세톤을 자화하는 상기의 새로운 미생물의 특징을 이용하여 메틸이소부틸키톤과 같이 알파 위치의 카보닐기를 가지는 메틸키톤류 물질을 같은 방법으로 산화시켜 엘-류신을 직접 행합성하는 엘-류신의 제조방법에 관한 것이다. 다음에는 본 공시균주의 제조방법에 대하여 설명한다. 우리나라 각지의 토양 시료를 아세톤을 유일한 탄소원으로하여 0.5% 아세톤이 포함된 최소배지에서 30℃로 2일에서 10일간 배양후 배양액을 역시유일한 탄소원으로 메틸에틸키톤(methyl ethyl ketone)이 0.5% 포함된 최소배지에서 다시 배양하여 이를 한천 영양 배지에 도말하였다. 이후 영양 배지에서 자란 미생물 콜로니(Coloy)를 분리하여 아세톤을 0.5% 포함한 최소 배지에서 배양하여 아세톤 자화능력을 점검하였다. 이 균주들을 아세톤이 유일한 탄소원인 최소배지에서 성장 시킨 후 여기에 메틸이소부틸키톤을 5% 첨가하여 30℃에서 진탕 배양하였다. 이후 상등액을 얇은 막 크로마토그라피(Thin-Layer Chromatography ; TSC)를 통하여 분석하여 류신과 같은 전개치를 가지는 물질을 생산하는 미생물을 분리하였다. 이와같은 발명자가 분리한 공시 균주의 세균학적 성질은 다음과 같다.The present invention is described in detail as follows. Microorganisms that grow with acetone as the sole carbon source grow by using pyruvic acid produced by oxidizing the methyl group of acetone to turn into acetol, which in turn oxidizes to make acetal, and continue to oxidize it. That is, various components of the cell are synthesized using pyruvic acid synthesized by continuously oxidizing the terminal methyl group. The present invention utilizes the characteristics of the new microorganisms to magnetize acetone and el-leucine which directly synthesizes el-leucine by oxidizing methyl-ketone substances having an alpha-carbonyl group such as methyl isobutyl ketone in the same manner. It relates to a manufacturing method of. Next, the method for producing the present strain will be described. Soil samples from all over Korea were incubated for 2 to 10 days at 30 ° C in a minimum medium containing 0.5% acetone as the only carbon source, and the culture medium was the only carbon source containing 0.5% methyl ethyl ketone. Recultured in minimal medium and plated in agar nutrient medium. Thereafter, microbial colonies (Coloy) grown in nutrient medium were separated and cultured in a minimal medium containing 0.5% of acetone to check acetone magnetization ability. These strains were grown in a minimal medium, where acetone was the only carbon source, and then cultured at 30 ° C with 5% methyl isobutyl ketone. The supernatant was then analyzed by thin layer chromatography (Thin-Layer Chromatography; TSC) to isolate microorganisms producing substances with developmental values, such as leucine. The bacteriological properties of the disclosed strains isolated by the inventors are as follows.

(1) 콜로니의 성상 : 황색, 원형(1) Appearance of colony: yellow, round

(2) 그람 염색 : 그람 음성(2) Gram dye: Gram negative

(3) 운동성 : 음성(3) mobility: voice

(4) 생화학적 성질(4) biochemical properties

생육온도 37℃ 이하Growth temperature below 37 ℃

카탈라아제(catalase)생성 양성Catalase production positive

인돌(Indole)의 생성 음성Generation voice of indole

젤라틴 가수분해능 음성Gelatin hydrolytic negative

셀로비오스(cellobiose)로부터 산 생성 양성Positive acid production from cellobiose

글리세롤(Glycerol)로부터 산 생성 음성Negative acid production from glycerol

말토오스(Maltose)로부터 산 생성 음성Acid production negative from maltose

만니톨(D-mannitol)로부터 산 생성 음성Acid production negative from mannitol

라피노오스(Raffinose)로부터 산 생성 양성Positive acid production from Raffinose

람노오스(L-Rhamnose)로부터 산 생성 양성Acid production positive from L-Rhamnose

살리신(Salicin)로부터 산 생성 양성Positive acid production from salicycin

슈크로오스(Sucrose)로부터 산 생성 양성Positive acid production from sucrose

라이신 탈탄산효소(Lysine decarboxylase) 음성Lysine decarboxylase negative

알지닌 탈수소료소(Arginine dehydroxylase) 음성Arginine dehydroxylase negative

오르니틴 탈탄산효소(Ornithine decarboxylase) 음성Ornithine decarboxylase negative

질산환원능(Nitrate reduction) 양성Nitrate reduction

에스큘린 가수분해능(Esculin hydrolysis) 양성Esculin hydrolysis positive

요소 가수분해능 음성Urea Hydrolysis Negative

이상의 세균학적 성질에 근거하여 대표적인 미생물 동정방법인 버기스 시스테마틱 오브 마이크로바이오러지(Bergey's Systematics of Microbiology)에 의해 동정한 결과 본 균주는 엔테로박타속으로 인지되며 엔테로박타 속 엠케이오 62(Enterobacter sp. MKO62)로 명명되어 1994년 11월 18일자로 한국과학기술원 유전공학연구소에 기탁번호 KCTC8634P로 기탁되어 있다.Based on the above bacteriological properties, this strain was recognized by Bergy's Systematics of Microbiology, a representative microbial identification method. MKO62) and was deposited on November 18, 1994, with the deposit number KCTC8634P at the Institute of Genetic Engineering, Korea Advanced Institute of Science and Technology.

한편, 본 발명에 따르면 상기의 균주의 배양은 pH 4.5∼0에서 실시하며, 바람직하게는 pH 6.0∼7.5에서 실시한다. 이때 배양은 20-40℃의 온도에서서, 바람직하게는 25-35℃에서 통상 실시한다. 성장에 필요한 탄소원으로서 아세톤은 통상 초기농도로 1%(V/V)를 사용한다. 이하에는 본 균주 엔테로박타 속 MKO62를 이용한 류신의 생산실시예를 들어 본 발명을 구체적으로 설명한다. 그러나 본 발명이 실시예에 국한되는 것은 아니다. 사용된 아세톤과 메틸이소부틸키톤의 분석은 기체 크로마토그라피(GS)를 이용하였다. 생성된 아미노산의 분석은 크로마토그라피(Thin-Layer Chromatography 또는 High Performance Liquid Chromatography)를 이용하였다.On the other hand, according to the present invention the culture of the above strain is carried out at pH 4.5-0, preferably at pH 6.0-7.5. At this time, the culture is usually carried out at a temperature of 20-40 ℃, preferably at 25-35 ℃. As a carbon source for growth, acetone is usually used at an initial concentration of 1% (V / V). Hereinafter, the present invention will be described in detail with reference to the production examples of leucine using the present strain Enterobacter MKO62. However, the present invention is not limited to the examples. Analysis of the acetone and methyl isobutyl ketone used was gas chromatography (GS). The generated amino acid was analyzed by chromatography (Thin-Layer Chromatography or High Performance Liquid Chromatography).

실시예 1Example 1

공시균주를 배양하고 다량의 균체를 얻기 위하여 다음과 같은 방법으로 실시하였다.The cultured test strains were carried out in the following manner to obtain a large amount of cells.

(배지조성)(Badge composition)

효모추출물 0.1%, 인산칼륨 0.5%, 황산암모늄 0.5%, 황산마그네슘 0.001%(pH 7.0, 121℃의 온도에서 15분간 가압멸균하여 식힌후 아세톤 용적비 1% 첨가)Yeast extract 0.1%, potassium phosphate 0.5%, ammonium sulfate 0.5%, magnesium sulfate 0.001% (pressurized by sterilization at a temperature of pH 7.0, 121 ℃ for 15 minutes and added 1% of acetone volume)

(배양)(culture)

2ℓ의 날개달린 삼각 플라스크에 200ml의 상기 배지를 넣고 여기에 토양에서 분리한 엔토박타속 MKO62를 접종시키고 20℃에서 36시간 동안 200rpm으로 진탕 배양한다. 600nm에서의 흡광도가 2정도에서 회수하여 배양액을 500rpm에서 20분동안 원심분리하여 상등액을 제거한후 균체를 영하 70℃에 얼려 보관하였다.200 ml of the medium was added to a 2 l winged Erlenmeyer flask, inoculated with Entobacterium MKO62 isolated from the soil, and incubated at 20 ° C. at 200 rpm for 36 hours. The absorbance at 600 nm was recovered at about 2 and the culture was centrifuged at 500 rpm for 20 minutes to remove the supernatant and the cells were frozen at -70 ° C.

(반응조건)(Reaction conditions)

완충용액(인산칼륨 0.1%, 황산암모늄 0.5%, 염화나트륨 0.01%, pH 7.0)으로 균체를 녹여 세적한후 균체를 600nm에서 흡광도가 20정도가 되도록 농축하여 반응용액 각각에 아세톤과 메틸이소부틸키톤을 2% 첨가하여 30℃에서 진탕 배양하였다. 6시간 동안 배양하면서 2시간마다 시료를 채취하여 아미노산을 분석하여 엘-류신의 생산성을 표1에 나타내었다.After dissolving the cells with buffer solution (0.1% potassium phosphate, ammonium sulfate 0.5%, sodium chloride 0.01%, pH 7.0), the cells were concentrated and absorbed at 600 nm until the absorbance was about 20. 2% was added and shake cultured at 30 degreeC. Samples are taken every 2 hours while incubating for 6 hours to analyze amino acids, and the productivity of L-leucine is shown in Table 1.

표 1. 엘-류신의 생성(단위 : 엘-류신 g/ℓ)Table 1. Production of L-Leucine (Unit: L-leucine g / l)

실시예 2Example 2

동일한 반응조건하에서 초기의 메틸이소부틸의 농도를 분산된 미생물 촉매상에 0%, 1%, 2%, 4%, 8%, 16%, 32% 첨가하여 30℃에서 6시간 동안 반응하였다.Under the same reaction conditions, the initial concentration of methyl isobutyl was added to 0%, 1%, 2%, 4%, 8%, 16%, 32% on the dispersed microbial catalyst and reacted at 30 ° C. for 6 hours.

실시예 3Example 3

미생물 세포막의 투과성을 증가시키는 물질로 알려져 있는 비이온성 계면활성제의 일종인 트리톤 엑스-100(TRITON X-100), 트윈(TWEEN)80, 염화칼슘, 이.디.티.에이(EDTA)등으로 미생물을 전처리하여 같은 방법으로 2%의 메틸이소부틸키톤을 첨가하여 30℃에서 6시간동안 반응하였다. 전처리하지 않은 대조군에 비하여 엘-류신의 생산의 증가를 확인하였다.It is a type of nonionic surfactant known to increase the permeability of microbial cell membranes such as TRITON X-100, TWEEN80, calcium chloride and E.D.T. After pretreatment, 2% methyl isobutyl ketone was added in the same manner and reacted at 30 ° C. for 6 hours. An increase in production of L-leucine was observed compared to the control that was not pretreated.

트리톤 엑스-100 1%(v/v) 엘-류신생산 증가Triton X-100 1% (v / v) production of L-leucine increased

트윈 80 1%(v/v) 영향없음Twin 80 1% (v / v) No effect

염화칼슘 (10mM) 영향없음Calcium chloride (10mM) No effect

EDTA (10mM) 영향없음EDTA (10mM) No effect

소듐도데실황산(0.1%) 엘-류신생산 증가Sodium Dodecyl Sulfate (0.1%) Increased L-Leucine Production

실시예 4Example 4

반응용액에 트리톤 엑스-100을 0.1%, 0.5%, 1% 첨가하여 30℃에서 6시간동안 반응하였다. 대조군에 비하여 트리톤 엑스-100의 첨가에 의한 엘-류신의 생산의 증가를 확인하였다.0.1%, 0.5%, 1% of Triton X-100 was added to the reaction solution, and the reaction was carried out at 30 ° C. for 6 hours. The increase in production of L-leucine by the addition of Triton X-100 was confirmed as compared to the control.

Claims (5)

아세톤 및 메틸에틸키톤을 단일 탄소원으로 자라며 메틸이소부틸키톤으로부터 엘-류신을 생산하는 균주 엔테로박타 속 MKO62(Enterobacter sp, MKO62, KCTC8634P)Enterocacter sp, MKO62, KCTC8634P, a strain of enterobacter sp. That grows acetone and methyl ethyl ketone as a single carbon source and produces el-leucine from methyl isobutyl ketone 제1항의 균주 엔테로박타 속 MKO62를 배양하여 메틸이소부틸키톤으로부터 엘-류신을 수득하는 엘-류신의 제조방법.A method for producing L-leucine, which obtains L-leucine from methyl isobutyl ketone by culturing the strain Enterobacta genus MKO62 of claim 1. 제2항에 있어서, 메틸이소부틸키톤의 초기농도가 2% 이상인 엘-류신의 제조방법.The method for producing L-leucine according to claim 2, wherein the initial concentration of methyl isobutyl ketone is at least 2%. 제2항에 있어서, 트리톤 엑스-100, 소디움도데실설페이트 중 어느 하나를 미생물 세포막 투과성 증가물질로 사용하는 엘-류신의 제조방법.The method for producing L-leucine according to claim 2, wherein any one of Triton X-100 and sodium dodecyl sulfate is used as a substance for increasing microbial cell membrane permeability. 제4항에 있어서, 1% 이하의 트리톤 엑스-100을 0.1%(v/v)에서 1%(v/v)까지 첨가하여 엘-류신을 제조하는 방법.The method of claim 4, wherein up to 1% Triton X-100 is added from 0.1% (v / v) to 1% (v / v) to produce L-leucine.
KR1019950005878A 1995-03-20 1995-03-20 Novel enterobacter which produce l-leucine from methyl isobutyl ketone and l-leucine producing method KR0136642B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019950005878A KR0136642B1 (en) 1995-03-20 1995-03-20 Novel enterobacter which produce l-leucine from methyl isobutyl ketone and l-leucine producing method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019950005878A KR0136642B1 (en) 1995-03-20 1995-03-20 Novel enterobacter which produce l-leucine from methyl isobutyl ketone and l-leucine producing method

Publications (2)

Publication Number Publication Date
KR960034400A KR960034400A (en) 1996-10-22
KR0136642B1 true KR0136642B1 (en) 1998-04-25

Family

ID=19410204

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950005878A KR0136642B1 (en) 1995-03-20 1995-03-20 Novel enterobacter which produce l-leucine from methyl isobutyl ketone and l-leucine producing method

Country Status (1)

Country Link
KR (1) KR0136642B1 (en)

Also Published As

Publication number Publication date
KR960034400A (en) 1996-10-22

Similar Documents

Publication Publication Date Title
US5356812A (en) Processes for production of optically active 3-phenyl-1,3-propanediol by asymmetric assimilation
US5468625A (en) α-L-Rhamnosidase for obtaining rhamnose, a process for its preparation and its use
CS224624B2 (en) Method for producing 2,5-diketo-d-gluconic acid or its salts
HU209842B (en) Process for producing of l-lysine and l-threonine amino acid
FR2461753A1 (en) PROCESS FOR THE PREPARATION OF A CEPHALOSPORINE BY FERMENTATION AND MICROORGANISM FOR CARRYING OUT SAID METHOD
US4686185A (en) Microorganism of new species of genus Streptomyces and use thereof for production of chitinase
JPS6322188A (en) Novel l-aminoacylase
KR0136642B1 (en) Novel enterobacter which produce l-leucine from methyl isobutyl ketone and l-leucine producing method
JP3168202B2 (en) Method for producing (R)-(-)-4-halo-3-hydroxybutyronitrile
US3630842A (en) Production of 3{40 ,5{40 -cyclic adenylic acid with micro-organisms
US4357425A (en) Process for producing L-amino acid oxidase
US5496715A (en) Process for preparing indigo
KR20050026531A (en) Process for producing theanine
CH679401A5 (en)
US5716815A (en) Method for preparing dimethylcarboxylic acid compounds
WO1992018637A1 (en) Method for the production of d-gluconic acid
KR910004451B1 (en) Streptomyces sp,kctc 8466p and enzyme for cell wall lysis
US3716454A (en) PROCESS FOR THE PRODUCTION OF alpha -AMINOBENZLPENICILLIN
JP3129773B2 (en) Method for producing D-ribose
Duménil et al. Production of vitamin B12 by gram-variable methanol-utilizing bacteria
JPS6221509B2 (en)
KR0184716B1 (en) Bacillus sp. lk-2 having d-alanine aminotransferase
JPH09131196A (en) New microorganism and its utilization
JP2702764B2 (en) Method for producing (7S) -cyclopenta [d] pyrimidine derivative
JPH0515394A (en) Production of optically active (s)-3-phenyl-1,3propanediol

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20090116

Year of fee payment: 12

LAPS Lapse due to unpaid annual fee